Mechanism of action of metformin
Although the detailed molecular mechanism of action of metformin is not fully understood, pharmacologists distinguish several proven components, including both peripheral and central effects.
- Tissue sensitization: the drug significantly increases the sensitivity of insulin-dependent tissues to the body's own (endogenous) insulin.
- Skeletal muscle: active stimulation of glucose uptake by myocytes occurs.
- Liver: metformin inhibits hepatic glucose production (gluconeogenesis).
- Gastrointestinal tract: intestinal glucose absorption is reliably reduced.
- Glucose utilization: anaerobic glycolysis is stimulated at the cellular level.
- Hormonal profile: a decrease in systemic glucagon levels is observed.
Metabolic effects and indications
Biguanides exert a complex effect on metabolism that goes beyond simple glycemic control. Of particular importance is their impact on the lipid profile: therapy with metformin is associated with a decrease in atherogenic low-density lipoproteins (LDL), as well as a drop in plasma total cholesterol (TC) and triglycerides (TG).
Equally important is the drug's effect on eating behavior—it helps reduce appetite, which naturally leads to weight loss.
Due to the combination of hypoglycemic action and weight loss, type 2 diabetes mellitus is the primary indication for prescribing biguanides. Moreover, metformin is recognized as the drug of choice for patients suffering from diabetes associated with overweight or obesity ("obese" patients).
Side effects
Adverse reactions to metformin are divided into two main categories:
- Dyspeptic disorders. These are the most frequent side effects. Patients often complain of nausea, vomiting episodes, diarrhea, severe flatulence, and abdominal pain. Although these symptoms are not life-threatening, they cause significant discomfort and often limit the use of the drug.
- Lactic acidosis. A specific and extremely dangerous side effect. Its pathogenesis is inextricably linked to the mechanism of action of biguanides: since metformin stimulates anaerobic glycolysis, the end product of this process—lactic acid—begins to accumulate in excess in the body. The clinical picture of lactic acidosis includes progressive weakness, drowsiness, severe muscle pain, dyspnea, drop in body temperature (hypothermia), and decreased heart rate (bradyarrhythmia).
Contraindications
Considering the pharmacodynamic features and the risks of severe complications, biguanides have a strict list of contraindications. The drug is strictly contraindicated in case of:
- Hypersensitivity to the active substance.
- Liver and kidney dysfunction. Impairment of these organs creates a high risk of metformin accumulation (cumulation), which exponentially increases the likelihood of lactic acidosis.
- Metabolic acidosis of any etiology.
- Pregnancy and lactation (breastfeeding).
Briefly: answers to topical questions
Which organs are responsible for the elimination of metformin and why is the drug contraindicated in their pathologies?
The sources do not specify the exact organs responsible for metformin elimination. In case of liver and kidney dysfunction, the drug is contraindicated due to the risk of accumulation and lactic acidosis.
For quick memorization of the metformin profile, use the three "S" rule: Sensitizes tissues to endogenous insulin, Suppresses appetite and body weight, Stimulates anaerobic glycolysis (which explains the risk of lactic acidosis).
Class and exam questions
How do biguanides lower blood sugar if they do not stimulate insulin production?
The hypoglycemic effect is achieved by increasing tissue sensitivity to endogenous insulin, stimulating glucose uptake by skeletal muscle, reducing hepatic glucose production, and decreasing intestinal absorption.
Why is metformin considered the drug of choice for type 2 diabetes mellitus in obese patients?
In addition to effective blood glucose control, metformin systemically affects eating behavior—it reduces appetite and promotes weight reduction. Additionally, it improves the lipid profile by lowering cholesterol, triglycerides, and atherogenic LDL.
What is the mechanism of lactic acidosis development during metformin therapy?
The pathogenesis of this dangerous complication is due to the drug's active stimulation of anaerobic glycolysis. The end product of this biochemical pathway is lactic acid, the excessive accumulation of which in the blood leads to severe acidosis.
Why is metformin strictly contraindicated in renal or hepatic diseases?
Impairment of these organs leads to delayed elimination and accumulation of the drug in the body. This critically increases the risk of developing lactic acidosis, which is accompanied by weakness, hypothermia, dyspnea, and bradyarrhythmia.
What else to study on this topic
- Central and peripheral mechanisms of metformin action at the cellular level
- Pathogenesis of lactic acidosis: biochemistry of anaerobic glycolysis and lactic acid accumulation
- Effect of biguanides on the lipid profile: mechanisms of LDL and triglyceride reduction
- Reasons for the withdrawal of buformin and phenformin from modern clinical practice
- Pharmacokinetics of metformin and mechanisms of its accumulation in renal and hepatic pathologies
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Biguanides" and 5,304 other subject pages
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in the section "Hormone preparations, their synthetic substitutes, and antagonists"
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.